Sema4|GeneDx to Provide Whole Genome Sequencing and Interpretation Services for Landmark Genomic Newborn Screening Study.  Learn more >>

Hereditary Sensory & Autonomic Neuropathy Panel

New York
Approved


Genes

ATL1, ATL3, DNMT1, DST, ELP1, KIF1A, NGF, NTRK1, PRDM12, RAB7A, FAM134B, SCN11A, SCN9A, SPTLC1, SPTLC2, WNK1

Conditions

  • Congenital Insensitivity to Pain with Anhidrosis
  • Hereditary Sensory and Autonomic Neuropathy (HSAN)
  • Inherited Erythromelalgia (IEM)
  • Paroxysmal Extreme Pain Disorder (PEPD)
  • Riley Day Syndrome
  • Small Fiber Neuropathy (SFN)
  • Episodic Pain Syndrome Type 3

Clinical Utility

  • Molecular confirmation of a clinical diagnosis
  • To assist with decisions about treatment and management of individuals with neuropathy
  • Testing of at-risk relatives for specific mutation(s) previously identified in an affected family member
  • Prenatal diagnosis for known familial mutation(s) in at-risk pregnancies

Lab Method

  • Next-Gen Sequencing
  • Deletion/Duplication Analysis

Test Code

T399

CPT Codes*

81448x1

ABN Required

No

Turnaround Time**

4 weeks

Preferred Specimen

2-5 mL Blood - Lavender Top Tube

Alternative Specimen

Buccal Swabs

*The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

**Reporting times are typical and begin once the sample(s) are received at the GeneDx laboratory, but could be extended in situations outside GeneDx’s reasonable control.